Dr. Rippee speaks about enrolling patients in Oxeia’s Phase 2 Clinical Trial for Concussions on KU’s Morning Medical Update

Apr 7

Dr. Michael Rippee, Medical Director for the Center for Concussion Management and a Sports Neurologist at the University of Kansas Medical Center, talks about enrolling participants and the exciting science behind Oxeia’s Phase 2 Concussion Trial.

John Hauschildt https://www.RumDoodle.com

Dr. Rippee speaks about enrolling patients in Oxeia’s Phase 2 Clinical Trial for Concussions on KU’s Morning Medical Update

KUMC: The University of Kansas Health System Center for Concussion Management will hold its 4th Annual Symposium on August 6, 2022.

Talking About Oxeia’s Phase 2 Clinical Trial for Concussion with Brain Injury Radio Host Kim Justus